Nancy E. Ward

2.3k total citations
65 papers, 1.9k citations indexed

About

Nancy E. Ward is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Nancy E. Ward has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in Nancy E. Ward's work include Protein Kinase Regulation and GTPase Signaling (18 papers), Retinal Development and Disorders (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Nancy E. Ward is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (18 papers), Retinal Development and Disorders (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Nancy E. Ward collaborates with scholars based in United States, China and Netherlands. Nancy E. Ward's co-authors include Catherine A. O’Brian, C A O'Brian, Constantin G. Ioannides, Jubilee R. Stewart, S. Eva Singletary, Dominic Fan, Isaiah J. Fidler, Diana Risin, Semyon A. Risin and Rob M. J. Liskamp and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.

In The Last Decade

Nancy E. Ward

65 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy E. Ward United States 27 1.3k 454 192 154 140 65 1.9k
Brian Herman United States 11 1.4k 1.1× 262 0.6× 162 0.8× 100 0.6× 192 1.4× 13 2.2k
P. Loppnau Canada 28 2.1k 1.6× 361 0.8× 127 0.7× 160 1.0× 150 1.1× 54 2.7k
Barbara Ardelt United States 23 1.3k 1.0× 480 1.1× 72 0.4× 138 0.9× 175 1.3× 40 2.0k
Anca D. Petrescu United States 27 1.6k 1.2× 394 0.9× 326 1.7× 87 0.6× 304 2.2× 59 2.4k
Peter Chase United States 24 1.2k 0.9× 221 0.5× 151 0.8× 164 1.1× 280 2.0× 68 2.0k
Eugenia M. Yazlovitskaya United States 25 1.2k 0.9× 423 0.9× 111 0.6× 103 0.7× 166 1.2× 48 1.9k
Ramsey Walden United States 10 1.2k 0.9× 421 0.9× 245 1.3× 62 0.4× 465 3.3× 19 2.1k
Pamela A. Benfield United States 31 2.4k 1.8× 556 1.2× 241 1.3× 292 1.9× 256 1.8× 39 4.0k
Thomas Herget Germany 31 1.7k 1.3× 240 0.5× 293 1.5× 110 0.7× 258 1.8× 59 2.7k
Young-In Chi United States 18 1.4k 1.0× 193 0.4× 293 1.5× 277 1.8× 161 1.1× 23 2.0k

Countries citing papers authored by Nancy E. Ward

Since Specialization
Citations

This map shows the geographic impact of Nancy E. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Ward more than expected).

Fields of papers citing papers by Nancy E. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy E. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Ward. The network helps show where Nancy E. Ward may publish in the future.

Co-authorship network of co-authors of Nancy E. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy E. Ward. A scholar is included among the top collaborators of Nancy E. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy E. Ward. Nancy E. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ward, Nancy E., et al.. (2022). Regulation of PP1 interaction with I-2, neurabin, and F-actin. Molecular and Cellular Neuroscience. 124. 103796–103796. 1 indexed citations
2.
Zhao, Qingqing, Changyi Ji, Ziao Fu, et al.. (2020). Structural and functional characterization of the bestrophin-2 anion channel. Nature Structural & Molecular Biology. 27(4). 382–391. 23 indexed citations
3.
Ji, Changyi, Yao Li, Nancy E. Ward, et al.. (2019). Investigation and Restoration of BEST1 Activity in Patient-derived RPEs with Dominant Mutations. Scientific Reports. 9(1). 19026–19026. 31 indexed citations
4.
Li, Yao, Yu Zhang, Yu Xu, et al.. (2018). Patient-Specific Mutations Impair Bestrophin1's Essential Role in Mediating Ca2+-Dependent CL- Currents in Human RPE. Biophysical Journal. 114(3). 306a–306a. 1 indexed citations
5.
6.
Lokesh, G.L., Hongyu Wang, Curtis H. Lam, et al.. (2017). X-Aptamer Selection and Validation. Methods in molecular biology. 1632. 151–174. 29 indexed citations
7.
Patel, Mamta, Michelle Sykes, Nancy E. Ward, et al.. (2007). Identification of mechanosensitive genes in osteoblasts by comparative microarray studies using the rotating wall vessel and the random positioning machine. Journal of Cellular Biochemistry. 101(3). 587–599. 79 indexed citations
8.
Ward, Nancy E., F. Chu, & Catherine A. O’Brian. (2002). Regulation of Protein Kinase C Isozyme Activity by S-Glutathiolation. Methods in enzymology on CD-ROM/Methods in enzymology. 353. 89–100. 15 indexed citations
9.
Carter, Darrick, Clay L. Efferson, Nancy E. Ward, et al.. (2002). Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Complex. The Journal of Immunology. 169(7). 3545–3554. 23 indexed citations
10.
Ward, Nancy E., Richard J. Epstein, Andrzej P. Kudelka, et al.. (2002). Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro. Oncology Reports. 9(5). 929–35. 3 indexed citations
11.
Ward, Nancy E., Catherine A. O’Brian, James L. Murray, et al.. (2001). Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity. Molecular and Cellular Biochemistry. 217(1-2). 21–33. 27 indexed citations
12.
O’Brian, Catherine A., Nancy E. Ward, Jubilee R. Stewart, & F. Chu. (2001). Prospects for Targeting Protein Kinase C Isozymes in the Therapy of Drug-resistant Cancer – An Evolving Story. Cancer and Metastasis Reviews. 20(1-2). 95–100. 28 indexed citations
13.
O'Brian, C A, et al.. (1994). The role of protein kinase C in multidrug resistance. Cancer treatment and research. 73. 41–55. 10 indexed citations
14.
15.
Ward, Nancy E. & Catherine A. O’Brian. (1992). The intrinsic ATPase activity of protein kinase C is catalyzed at the active site of the enzyme. Biochemistry. 31(25). 5905–5911. 19 indexed citations
16.
17.
O’Brian, Catherine A. & Nancy E. Ward. (1990). Characterization of a calcium- and phospholipid-dependent ATPase reaction catalyzed by rat brain protein kinase C. Biochemistry. 29(18). 4278–4282. 13 indexed citations
18.
O’Brian, Catherine A., Constantin G. Ioannides, Nancy E. Ward, & Rob M. J. Liskamp. (1990). Inhibition of protein kinase C and calmodulin by the geometric isomers cis‐ and trans‐tamoxifen. Biopolymers. 29(1). 97–104. 29 indexed citations
19.
O’Brian, Catherine A., Dominic Fan, Nancy E. Ward, Christopher A. Seid, & Isaiah J. Fidler. (1989). Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. FEBS Letters. 246(1-2). 78–82. 74 indexed citations
20.
O’Brian, Catherine A. & Nancy E. Ward. (1989). Binding of protein kinase C to N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide through its ATP binding site. Biochemical Pharmacology. 38(11). 1737–1742. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Herman Breakdown of academic impact, for papers by P. Loppnau Breakdown of academic impact, for papers by Barbara Ardelt Breakdown of academic impact, for papers by Anca D. Petrescu Breakdown of academic impact, for papers by Peter Chase Breakdown of academic impact, for papers by Eugenia M. Yazlovitskaya Breakdown of academic impact, for papers by Ramsey Walden Breakdown of academic impact, for papers by Pamela A. Benfield Breakdown of academic impact, for papers by Thomas Herget Breakdown of academic impact, for papers by Young-In Chi
Rankless by CCL
2026